Brind.

Ionis Pharmaceuticals is seeking FDA approval for its treatments for Alexander disease, including Tryngolza, and has formed new partnerships with AstraZeneca and Hoffmann-La Roche.

Steady: 0 in the last 7 days Updated sep 20

The latest in this situation

  1. Ionis Pharmaceuticals is successfully treating Alexander disease using its drug Zanvastro.
  2. FDA grants approval for Ionis's Zanvastro for Alexander disease.

How it started

2 reports, 2 independent, last reported Sep 11. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Ionis Pharmaceuticals is seeking FDA approval for its treatments for Alexander disease, including Tryngolza, and has formed new partnerships with AstraZeneca and Hoffmann-La Roche.

Who's involved

What this event is mainly about
Ionis PharmaceuticalsFDAAstraZeneca

How it developed

Newest first. Tap a step to see who reported it.
  1. Ionis Pharmaceuticals is successfully treating Alexander disease using its drug Zanvastro.Sub-event
  2. FDA grants approval for Ionis's Zanvastro for Alexander disease.1 source
  3. Ionis seeks FDA approval for Alexander disease treatments and announces partnerships with AstraZeneca and Roche.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped